by admin | Feb 11, 2016 | Archive
February 11, 2016 Because modern versions tend to have a microbial foundation, eventual resistance to antibiotics is expected and typically surfaces within a few years after a new product becomes available. Resistance to carbapenem—especially in the... by admin | Feb 11, 2016 | Archive
February 11, 2016 Walgreens has reportedly warned Theranos it may terminate its relationship unless the blood-testing company quickly fixes the problems found by federal inspectors at a laboratory in California. The warning was issued late last month and gives... by admin | Feb 11, 2016 | Archive
February 11, 2016 Following reports of meningitis B cases in Santa Clara, CA, Walgreens announced that its 15 pharmacies there would offer vaccinations against the disease. “We support the recommendations of local health officials and stress that vaccination is... by admin | Feb 11, 2016 | Archive
February 11, 2016 A recent Phase II study investigated the use of caplacizumab for the treatment of acquired thrombotic thrombocytopenic purpura (TTP), a rare blood-clotting disorder. Researchers randomly assigned 75 patients with acquired TTP to subcutaneous... by admin | Feb 11, 2016 | Archive
February 11, 2016 Amid mounting concern over compounding pharmacies that include physicians among their owners or investors, officials in Texas are trying to halt what many view as a kickback scheme. While doctors’ financial affiliations are permissible if... by admin | Feb 11, 2016 | Archive
February 11, 2016 Mylan NV has inked a deal to acquire Meda AB for $7.2 billion. The deal follows an attempt to buy the Swedish drug company in 2014 and comes after Mylan lost a $26 billion hostile bid for Perrigo in November. Mylan said the sale will give the company...